Activator protein 1 (AP-1)- and nuclear factor κB (NF-κB)-dependent transcriptional events in carcinogenesis

Free Radical Biology and Medicine

Volumn 28, Issue 9, 2000, Pages 1338-1348

  Hsu, Tin Chen ^b   Young, Matthew R ^a   Cmarik, Joan ^a   Colburn, Nancy H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

AP 1; Free radical; JB6 cells; NF B; Tumor promotion

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1; TUMOR PROMOTER;

ANIMAL CELL; CARCINOGENESIS; CELL TRANSFORMATION; CYTOTOXICITY; EPIDERMIS CELL; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TUMOR PROMOTION;

EID: 0034190272     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00220-3     Document Type: Article

References (168)

1. Cerutti P.A. Pro-oxidant states and tumor promotion. Science. 227:1985;375-381.
2. Floyd R.A. Oxidative damage to behavior during aging. Science. 254:1991;1597.
3. Fridovich, I. Oxygen free radicals and tissue damage: Chairman's introduction. Ciba Found Symp. 1978:1-4.
4. Fridovich, I. Superoxide dismutases: Defense against endogenous superoxide radical. Ciba Found Symp. 1978:77-93.
5. Weitzman S.A., Weitberg A.B., Clark E.P., Stossel T.P. Phagocytes as carcinogens malignant transformation produced by human neutrophils . Science. 227:1985;1231-1233.
6. Cerutti P.A., Trump B.F. Inflammation and oxidative stress in carcinogenesis. Cancer Cells. 3:1991;1-7.
7. Dalton T.P., Shertzer H.G., Puga A. Regulation of gene expression by reactive oxygen. Ann. Rev. Pharmacol. Toxicol. 39:1999;67-101.
8. Singh N., Aggarwal S. The effect of active oxygen generated by xanthine/xanthine oxidase on genes and signal transduction in mouse epidermal JB6 cells. Int. J. Cancer. 62:1995;107-114.
9. Beckman K.B., Ames B.N. Oxidative decay of DNA. J. Biol. Chem. 272:1997;19633-19636.
10. Cimino F., Esposito F., Ammendola R., Russo T. Gene regulation by reactive oxygen species. Curr. Top. Cell. Regul. 35:1997;123-148.
11. Baeuerle P.A., Rupec R.A., Pahl H.L. Reactive oxygen intermediates as second messengers of a general pathogen response. Pathol. Biol. (Paris). 44:1996;29-35.
12. Bauer P.M., Fukuto J.M., Buga G.M., Pegg A.E., Ignarro L.J. Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. Biochem. Biophys. Res. Commun. 262:1999;355-358.
13. Halliwell B. How to characterize a biological antioxidant. Free Radic. Res. Commun. 9:1990;1-32.
14. Kinscherf R., Fischbach T., Mihm S., Roth S., Hohenhaus-Sievert E., Weiss C., Edler L., Bartsch P., Droge W. Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4+ and CD8+ cells. FASEB J. 8:1994;448-451.
15. Amstad P., Peskin A., Shah G., Mirault M.E., Moret R., Zbinden I., Cerutti P. The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry. 30:1991;9305-9313.
16. Deby C., Goutier R. New perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases. Biochem. Pharmacol. 39:1990;399-405.
17. Sun Y., Colburn N.H., Oberley L.W. Depression of catalase gene expression after immortalization and transformation of mouse liver cells. Carcinogenesis. 14:1993;1505-1510.
18. Sun Y., Nakamura K., Wendel E., Colburn N. Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. USA. 90:1993;2827-2831.
19. Sun Y., Colburn N.H., Oberley L.W. Decreased expression of manganese superoxide dismutase mRNA and protein after immortalization and transformation of mouse liver cells. Oncol. Res. 5:1992;127-132.
20. Warner B.B., Stuart L., Gebb S., Wispe J.R. Redox regulation of manganese superoxide dismutase. Am. J. Physiol. 271:(Suppl.):1996;L150-L158.
21. Primiano T., Sutter T.R., Kensler T.W. Redox regulation of genes that protect against carcinogens. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 118:1997;487-497.
22. Primiano T., Sutter T.R., Kensler T.W. Antioxidant-inducible genes. Adv. Pharmacol. 38:1997;293-328.
23. Jain P.T., Chang S.H., Berezesky I.K., Amstad P., Cerutti P.A., Trump B.F. Differential cytotoxicity in mouse epidermal JB6 cells a potential mechanism for oxidant tumor promotion . Mol. Carcin. 11:1994;164-169.
24. Colburn N.H. Gene regulation by active oxygen and other stress inducers role in tumor promotion and progression . Spatz L., Bloom A.D., Biological consequences of oxidative stress implications for cardiovascular disease and carcinogenesis. 1992;122-137 Oxford University Press, Oxford.
25. Burdon R.H., Gill V., Rice-Evans C. Oxidative stress and tumour cell proliferation. Free Radic. Res. Commun. 11:1990;65-76.
26. Burdon R.H., Gill V., Rice-Evans C. Reduction of a tetrazolium salt and superoxide generation in human tumor cells (HeLa). Free Radic. Res. Commun. 18:1993;369-380.
27. Fujii J., Taniguchi N. Phorbol ester induces manganese-superoxide dismutase in tumor necrosis factor-resistant cells. J. Biol. Chem. 266:1991;23142-23146.
28. Simon L.M., Robin E.D., Theodore J. Differences in oxygen-dependent regulation of enzymes between tumor and normal cell systems in culture. J. Cell. Physiol. 108:1981;393-400.
29. Porta C., Moroni M., Guallini P., Torri C., Marzatico F. Antioxidant enzymatic system and free radicals pathway in two different human cancer cell lines. Anticancer Res. 16:1996;2741-2747.
30. Gasdaska J.R., Berggren M., Powis G. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell. Growth Differ. 6:1995;1643-1650.
31. Gallegos A., Berggren M., Gasdaska J.R., Powis G. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res. 57:1997;4965-4970.
32. Li J.J., Oberley L.W., Fan M., Colburn N.H. Inhibition of AP-1 and NF-κB by manganese-containing superoxide dismutase in human breast cancer cells. FASEB J. 12:1998;1713-1723.
33. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic. Biol. Med. 8:1990;583-599.
34. Cerutti P.A. Oxidant stress and carcinogenesis. Eur. J. Clin. Invest. 21:1991;1-5.
35. Cerutti P., Ghosh R., Oya Y., Amstad P. The role of the cellular antioxidant defense in oxidant carcinogenesis. Environ. Health Perspec. 102:(Suppl. 10):1994;123-129.
36. Melendez J.A., Baglioni C. Reduced expression of manganese superoxide dismutase in cells resistant to cytolysis by tumor necrosis factor. Free Radic. Biol. Med. 12:1992;151-159.
37. Oberley L.W., Oberley T.D. Role of antioxidant enzymes in cell immortalization and transformation. Mol. Cell. Biochem. 84:1988;147-153.
38. Borrello S., De Leo M.E., Galeotti T. Defective gene expression of MnSOD in cancer cells. Mol. Aspects Med. 14:1993;253-258.
39. Church S.L., Grant J.W., Ridnour L.A., Oberley L.W., Swanson P.E., Meltzer P.S., Trent J.M. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl. Acad. Sci. USA. 90:1993;3113-3117.
40. Amstad P.A., Liu H., Ichimiya M., Berezesky I.K., Trump B.F. Manganese superoxide dismutase expression inhibits soft agar growth in JB6 clone41 mouse epidermal cells. Carcinogenesis. 18:1997;479-484.
41. Liu R., Oberley T.D., Oberley L.W. Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. Hum. Gene Ther. 8:1997;585-595.
42. Liu B., Whisler R.L. Transcriptional activation and redox regulation of the tumor necrosis factor-alpha promoter in human T cells role of the CRE/kappa3 promoter region . J. Interferon Cytokine Res. 18:1998;999-1007.
43. Bernstein L.R., Colburn N.H. AP1/jun function is differentially induced in promotion-sensitive and -resistant JB6 cells. Science. 244:1989;566-569.
44. Bernstein L.R., Ben-Ari E.T., Simek S.L., Colburn N.H. Gene regulation and genetic susceptibility to neoplastic transformation AP-1 and p80 expression in JB6 cells . Environ. Health Perspec. 93:1991;111-119.
45. Colburn N.H., Smith B.M. Genes that cooperate with tumor promoters in transformation. J. Cell. Biochem. 34:1987;129-142.
46. Singh N., Sun Y., Nakamura K., Smith M.R., Colburn N.H. C-Jun/AP-1 as possible mediators of tumor necrosis factor α-induced apoptotic response in mouse JB6 tumor cells. Oncol. Res. 7:1995;353-362.
47. Cmarik J.L., Colburn N.H. Use of mouse JB6 cells to identify molecular targets and novel agents for prevention of carcinogenesis. Ohigashi H., et al. Proceedings of the International Conference on Food Factors Chemistry and Cancer Prevention . 1997;67-76 Springer-Verlag, Tokyo.
48. Cerutti P., Shah G., Peskin A., Amstad P. Oxidant carcinogenesis and antioxidant defense. Ann. NY Acad. Sci. 663:1992;158-166.
49. Nakamura Y., Colburn N.H., Gindhart T.D. Role of reactive oxygen in tumor promotion implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA . Carcinogenesis. 6:1985;229-235.
50. Nakamura Y., Gindhart T.D., Winterstein D., Tomita I., Seed J.L., Colburn N.H. Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells. Carcinogenesis. 9:1988;203-207.
51. Crawford D.R., Amstad P.A., Foo D.D., Cerutti P.A. Constitutive and phorbol-myristate-acetate regulated antioxidant defense of mouse epidermal JB6 cells. Mol. Carcin. 2:1989;136-143.
52. Bernstein L.R., Ferris D.K., Colburn N.H., Sobel M.E. A family of mitogen-activated protein kinase-related proteins interacts in vivo with activator protein 1 transcription factor. J. Biol. Chem. 269:1994;9401-9404.
53. Watts R.G., Huang C., Young M.R., Li J.J., Dong Z., Pennie W.D., Colburn N.H. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene. 17:1998;3493-3498.
54. Huang C., Ma W.Y., Young M.R., Colburn N., Dong Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl. Acad. Sci. USA. 95:1998;156-161.
55. Li J.J., Colburn N.H., Oberley L.W. Maspin gene expression in tumor suppression induced by overexpressing manganese-containing superoxide dismutase cDNA in human breast cancer cells. Carcinogenesis. 19:1998;833-839.
56. Xanthoudakis S., Miao G., Wang F., Pan Y.C., Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. Embo. J. 11:1992;3323-3335.
57. Toledano M.B., Leonard W.J. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA. 88:1991;4328-4332.
58. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor κB an oxidative stress-responsive transcription factor of eukaryotic cells (a review) . Free Radic. Res. Commun. 17:1992;221-237.
59. Muller J.M., Rupec R.A., Baeuerle P.A. Study of gene regulation by NF-κB and AP-1 in response to reactive oxygen intermediates. Methods. 11:1997;301-312.
60. Okuno H., Akahori A., Sato H., Xanthoudakis S., Curran T., Iba H. Escape from redox regulation enhances the transforming activity of Fos. Oncogene. 8:1993;695-701.
61. Devary Y., Rosette C., DiDonato J.A., Karin M. NF-κB activation by ultraviolet light not dependent on a nuclear signal. Science. 261:1993;1442-1445.
62. Manna S.K., Zhang H.J., Yan T., Oberley L.W., Aggarwal B.B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein 1. J. Biol. Chem. 273:1998;13245-13254.
63. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
64. Los M., Droge W., Stricker K., Baeuerle P.A., Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25:1995;159-165.
65. Meyer M., Schreck R., Baeuerle P.A. H2O2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells AP-1 as secondary antioxidant-responsive factor . Embo. J. 12:1993;2005-2015.
66. Meyer M., Pahl H.L., Baeuerle P.A. Regulation of the transcription factors NF-κB and AP-1 by redox changes. Chem. Biol. Interact. 91:1994;91-100.
67. Ginn-Pease M.E., Whisler R.L. Redox signals and NF-κB activation in T cells. Free Radic. Biol. Med. 25:1998;346-361.
68. Janssen-Heininger Y.M., Macara I., Mossman B.T. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-κB requirement of Ras/mitogen-activated protein kinases in the activation of NF-κB by oxidants . Am. J. Respir. Cell. Mol. Biol. 20:1999;942-952.
69. Milligan S.A., Owens M.W., Grisham M.B. Differential regulation of extracellular signal-regulated kinase and nuclear factor-κB signal transduction pathways by hydrogen peroxide and tumor necrosis factor. Arch. Biochem. Biophys. 352:1998;255-262.
70. Pinkus R., Weiner L.M., Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-κB, and glutathione S-transferase gene expression. J. Biol. Chem. 271:1996;13422-13429.
71. Anderson M.T., Staal F.J., Gitler C., Herzenberg L.A. Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc. Natl. Acad. Sci. USA. 91:1994;11527-11531.
72. Li N., Karin M. Is NF-κB the sensor of oxidative stress? FASEB J. 13:1999;1137-1143.
73. Bowie A.G., Moynagh P.N., O'Neill L.A.J. Lipid peroxidation is involved in the activation of NF-κB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. Lack of involvement of H2O2 in NF-κB activation by either cytokine in both primary and transformed endothelial cells. J. Biol. Chem. 272:1997;25941-25950.
74. Li J.J., Westergaard C., Ghosh P., Colburn N.H. Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res. 57:1997;3569-3576.
75. Suzuki Y.J., Mizuno M., Packer L. Signal transduction for nuclear factor-κB activation. Proposed location of antioxidant-inhibitable step. J. Immunol. 153:1994;5008-5015.
76. Kretz-Remy C., Mehlen P., Mirault M.E., Arrigo A.P. Inhibition of I κB-α phosphorylation and degradation and subsequent NF-κB activation by glutathione peroxidase overexpression. J. Cell. Biol. 133:1996;1083-1093.
77. Jin D.Y., Chae H.Z., Rhee S.G., Jeang K.T. Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation. J. Biol. Chem. 272:1997;30952-30961.
78. Brennan P., O'Neill L.A. Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines evidence against a universal hypothesis involving oxygen radicals . Biochim. Biophys. Acta. 1260:1995;167-175.
79. Suzuki Y.J., Mizuno M., Packer L. Transient overexpression of catalase does not inhibit TNF- or PMA-induced NF-κB activation. Biochem. Biophys. Res. Commun. 210:1995;537-541.
80. Angel P., Allegretto E.A., Okino S.T., Hattori K., Boyle W.J., Hunter T., Karin M. Oncogene jun encodes a sequence-specific transactivator similar to AP-1. Nature. 332:1988;166-171.
81. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 49:1987;741-752.
82. Forrest D., Curran T. Crossed signals oncogenic transcription factors . Curr. Opin. Genet. Dev. 2:1992;19-27.
83. Curran T. Fos and Jun oncogenic transcription factors . Tohoku J. Exp. Med. 168:1992;169-174.
84. Amstad P.A., Krupitza G., Cerutti P.A. Mechanism of c-fos induction by active oxygen. Cancer Res. 52:1992;3952-3960.
85. Stein B., Rahmsdorf H.J., Steffen A., Litfin M., Herrlich P. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol. Cell. Biol. 9:1989;5169-5181.
86. Djavaheri-Mergny M., Mergny J.L., Bertrand F., Santus R., Maziere C., Dubertret L., Maziere J.C. Ultraviolet-A induces activation of AP-1 in cultured human keratinocytes. FEBS Lett. 384:1996;92-96.
87. Heintz N.H., Janssen Y.M., Mossman B.T. Persistent induction of c-fos and c-jun expression by asbestos. Proc. Natl. Acad. Sci. USA. 90:1993;3299-3303.
88. Puga A., Nebert D.W., Carrier F. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell. Biol. 11:1992;269-281.
89. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:1995;16483-16486.
90. Peus D., Vasa R.A., Beyerle A., Meves A., Krautmacher C., Pittelkow M.R. UVB activates ERK1/2 and p38 signaling pathways via reactive oxygen species in cultured keratinocytes. J. Invest. Dermatol. 112:1999;751-756.
91. Rupec R.A., Baeuerle P.A. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-κB. Eur. J. Biochem. 234:1995;632-640.
92. Schenk H., Klein M., Erdbrugger W., Droge W., Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA. 91:1994;1672-1676.
93. Buscher M., Rahmsdorf H.J., Litfin M., Karin M., Herrlich P. Activation of the c-fos gene by UV and phorbol ester different signal transduction pathways converge to the same enhancer element . Oncogene. 3:1988;301-311.
94. Devary Y., Gottlieb R.A., Lau L.F., Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol. 11:1991;2804-2811.
95. Bannister A.J., Gottlieb T.M., Kouzarides T., Jackson S.P. c-Jun is phosphorylated by the DNA-dependent protein kinase in vitro definition of the minimal kinase recognition motif . Nucleic Acids Res. 21:1993;1289-1295.
96. Binetruy B., Smeal T., Karin M. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature. 351:1991;122-127.
97. Boyle W.J., Smeal T., Defize L.H., Angel P., Woodgett J.R., Karin M., Hunter T. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell. 64:1991;573-584.
98. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
99. Engelberg D., Klein C., Martinetto H., Struhl K., Karin M. The UV response involving the Ras signaling pathway and AP-1 transcription factors is conserved between yeast and mammals. Cell. 77:1994;381-390.
100. Lander H.M., Ogiste J.S., Teng K.K., Novogrodsky A. P21ras as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270:1995;21195-21198.
101. Deng T., Karin M. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature. 371:1994;171-175.
102. Xanthoudakis S., Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. Embo. J. 11:1992;653-665.
103. Abate C., Patel L., Rauscher F.J.D., Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science. 249:1990;1157-1161.
104. Matthews J.R., Wakasugi N., Virelizier J.L., Yodoi J., Hay R.T. Thioredoxin regulates the DNA-binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20:1992;3821-3830.
105. Matthews J.R., Kaszubska W., Turcatti G., Wells T.N., Hay R.T. Role of cysteine62 in DNA recognition by the P50 subunit of NF-κB. Nucleic Acids Res. 21:1993;1727-1734.
106. Ng L., Forrest D., Curran T. Differential roles for Fos and Jun in DNA binding redox-dependent and independent functions . Nucleic Acids Res. 21:1993;5831-5837.
107. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Ann. Rev. Immunol. 15:1997;351-369.
108. Hirota K., Matsui M., Iwata S., Nishiyama A., Mori K., Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA. 94:1997;3633-3638.
109. Diamond D.A., Parsian A., Hunt C.R., Lofgren S., Spitz D.R., Goswami P.C., Gius D. Redox factor-1 (Ref-1) mediates the activation of AP-1 in HeLa and NIH 3T3 cells in response to heat shock. J. Biol. Chem. 274:1999;16959-16964.
110. Gius D., Botero A., Shah S., Curry H.A. Intracellular oxidation/reduction status in the regulation of transcription factors NF-κB and AP-1. Toxicol. Lett. 106:1999;93-106.
111. Ben-Ari E.T., Bernstein L.R., Colburn N.H. Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation. Mol. Carcin. 5:1992;62-74.
112. Li J.J., Dong Z., Dawson M.I., Colburn N.H. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res. 56:1996;483-489.
113. Watts R.G., Ben-Ari E.T., Bernstein L.R., Birrer M.J., Winterstein D., Wendel E., Colburn N.H. c-jun and multistage carcinogenesis association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation . Mol. Carcin. 13:1995;27-36.
114. Huang C., Ma W.Y., Dong Z. The extracellular signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cells. Oncogene. 18:1999;2828-2835.
115. Young M.R., Li J.J., Rincon M., Flavell R.A., Sathyanarayana B.K., Hunziker R., Colburn N. Transgenic mice demonstrate AP-1 (activator protein 1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. USA. 96:1999;9827-9832.
116. Li J.J., Rhim J.S., Schlegel R., Vousden K.H., Colburn N.H. Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene. 16:1998;2711-2721.
117. Stein B., Baldwin A.S. Jr, Ballard D.W., Greene W.C., Angel P., Herrlich P. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. Embo. J. 12:1993;3879-3891.
118. Baldwin A.S. Jr. The NF-κB and I κB proteins new discoveries and insights . Ann. Rev. Immunol. 14:1996;649-683.
119. Beauparlant P., Kwan I., Bitar R., Chou P., Koromilas A.E., Sonenberg N., Hiscott J. Disruption of IκBα regulation by antisense RNA expression leads to malignant transformation. Oncogene. 9:1994;3189-3197.
120. Finco T.S., Westwick J.K., Norris J.L., Beg A.A., Der C.J., Baldwin A.S. Jr. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J. Biol. Chem. 272:1997;24113-24116.
121. Gilmore T.D., Koedood M., Piffat K.A., White D.W. Rel/NF-κB/IκB proteins and cancer. Oncogene. 13:1996;1367-1378.
122. Higgins K.A., Perez J.R., Coleman T.A., Dorshkind K., McComas W.A., Sarmiento U.M., Rosen C.A., Narayanan R. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA. 90:1993;9901-9905.
123. Luque I., Gelinas C. Rel/NF-κB and IκB factors in oncogenesis. Semin. Cancer Biol. 8:1997;103-111.
124. Sovak M.A., Bellas R.E., Kim D.W., Zanieski G.J., Rogers A.E., Traish A.M., Sonenshein G.E. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100:1997;2952-2960.
125. Visconti R., Cerutti J., Battista S., Fedele M., Trapasso F., Zeki K., Miano M.P., de Nigris F., Casalino L., Curcio F., Santoro M., Fusco A. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NF-κB p65 protein expression. Oncogene. 15:1997;1987-1994.
126. Latimer M., Ernst M.K., Dunn L.L., Drutskaya M., Rice N.R. The N-terminal domain of IκB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers. Mol. Cell. Biol. 18:1998;2640-2649.
127. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNFα-induced apoptosis by NF-κB [see comments]. Science. 274:1996;787-789.
128. Onishi Y., Kizaki H. Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. Biochem. Biophys. Res. Commun. 228:1996;7-13.
129. Shibahara K., Asano M., Ishida Y., Aoki T., Koike T., Honjo T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene. 166:1995;297-301.
130. Cmarik J.L., Min H., Hegamyer G., Zhan S., Kulesz-Martin M., Yoshinaga H., Matsuhashi S., Colburn N.H. Differentially expressed protein pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc. Natl. Acad. Sci. USA. 96:1999;14037-14042.
131. Jansen A.P., Colburn N.H., Verma A.K. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation [In Process Citation]. Oncogene. 18:1999;5806-5813.
132. Smith J.H., Denhardt D.T. Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells induction is stable at high, but not at low, cell densities . J. Cell. Biochem. 34:1987;13-22.
133. Craig A.M., Smith J.H., Denhardt D.T. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. J. Biol. Chem. 264:1989;9682-9689.
134. Su L., Mukherjee A.B., Mukherjee B.B. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. Oncogene. 10:1995;2163-2169.
135. Chang P.L., Lee T.F., Garretson K., Prince C.W. Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways. Clin. Exp. Metastasis. 15:1997;580-592.
136. Chang P.L., Yang W.C., Prince C.W. Effects of okadaic acid on calcitriol- and phorbol ester-induced expression and phosphorylation of osteopontin in mouse JB6 epidermal cells. Ann. NY Acad. Sci. 760:1995;24-34.
137. Chang P.L., Ridall A.L., Prince C.W. Calcitriol regulation of osteopontin expression in mouse epidermal cells. Endocrinology. 135:1994;863-869.
138. Sun Y., Hegamyer G., Colburn N.H. Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells one is homologous to human tissue inhibitor of metalloproteinases-3 . Cancer Res. 54:1994;1139-1144.
139. Smith J.S. Jr, Wey H.E., Leikauf G.D., Baxter C.S. JB6 murine epidermal cell lines sensitive and resistant to 12-O- tetradecanoylphorbol-13-acetate (TPA)-induced transformation exhibit differential arachidonic acid metabolism in response to TPA and the calcium ionophore A23187. Carcinogenesis. 13:1992;189-192.
140. Colburn N.H., Smith B.M., Wendel E.J., Nakamura Y., Winterstein D. Comparison of mouse pro-1 and pro-2 transfectants for responses to tumor promoters and antipromoters. Cancer Res. 48:1988;6076-6080.
141. Lemmon M.A., Ferguson K.M. Pleckstrin homology domains. Curr. Top. Microbiol. Immunol. 228:1998;39-74.
142. Tyers M., Haslam R.J., Rachubinski R.A., Harley C.B. Molecular analysis of pleckstrin the major protein kinase C substrate of platelets . J. Cell. Biochem. 40:1989;133-145.
143. Bustin M., Alfonso P.J., Pash J.M., Ward J.M., Gearhart J.D., Reeves R.H. Characterization of transgenic mice with an increased content of chromosomal protein HMG-14 in their chromatin. DNA Cell. Biol. 14:1995;997-1005.
144. Tallini G., Dal Cin P. HMGI(Y) and HMGI-C dysregulation a common occurrence in human tumors . Adv. Anat. Pathol. 6:1999;237-246.
145. Perrella M.A., Pellacani A., Wiesel P., Chin M.T., Foster L.C., Ibanez M., Hsieh C.M., Reeves R., Yet S.F., Lee M.E. High mobility group-I(Y) protein facilitates nuclear factor-κB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer. J. Biol. Chem. 274:1999;9045-9052.
146. Ogram S.A., Reeves R. Differential regulation of a multipromoter gene. Selective 12-O-tetradecanoylphorbol-13-acetate induction of a single transcription start site in the HMG-I/Y gene. J. Biol. Chem. 270:1995;14235-14242.
147. Cmarik J.L., Li Y., Ogram S.A., Min H., Reeves R., Colburn N.H. Tumor promoter induces high-mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells. Oncogene. 16:1998;3387-3396.
148. Schmidt K.N., Traenckner E.B., Meier B., Baeuerle P.A. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-κB. J. Biol. Chem. 270:1995;27136-27142.
149. Schmidt K.N., Amstad P., Cerutti P., Baeuerle P.A. Identification of hydrogen peroxide as the relevant messenger in the activation pathway of transcription factor NF-κB. Adv. Exp. Med. Biol. 387:1996;63-68.
150. Dong Z., Birrer M.J., Watts R.G., Matrisian L.M., Colburn N.H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA. 91:1994;609-613.
151. Huang C., Ma W.Y., Dong Z. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol. Cell. Biol. 16:1996;6427-6435.
152. Huang C., Schmid P.C., Ma W.Y., Schmid H.H., Dong Z. Phosphatidylinositol-3 kinase is necessary for 12-O- tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation. J. Biol. Chem. 272:1997;4187-4194.
153. Sun Y., Hegamyer G., Kim H., Sithanandam K., Li H., Watts R., Colburn N.H. Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation. J. Biol. Chem. 270:1995;19312-19319.
154. Pennie W.D., Hegamyer G.A., Young M.R., Colburn N.H. Specific methylation events contribute to the transcriptional repression of the mouse tissue inhibitor of metalloproteinases-3 gene in neoplastic cells. Cell. Growth Differ. 10:1999;279-286.
155. Huang C., Li J., Ma W.Y., Dong Z. JNK activation is required for JB6 cell transformation induced by tumor necrosis factor α but not by 12-O-tetradecanoylphorbol-13-acetate [In Process Citation]. J. Biol. Chem. 274:1999;29672-29676.
156. Amstad P.A., Liu H., Ichimiya M., Chang S., Berezesky I.K., Trump B.F. Bcl-2 enhancement of malignant transformation in mouse epidermal JB6 cells. Mol. Carcin. 20:1997;231-239.
157. Bernstein L.R., Bravo R., Colburn N.H. 12-O-tetradecanoylphorbol-13-acetate-induced levels of AP-1 proteins a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells . Mol. Carcin. 6:1992;221-229.
158. Smith B.M., Colburn N.H. Protein kinase C and its substrates in tumor promoter-sensitive and -resistant cells. J. Biol. Chem. 263:1988;6424-6431.
159. Simek S.L., Kligman D., Patel J., Colburn N.H. Differential expression of an 80-kDa protein kinase C substrate in preneoplastic and neoplastic mouse JB6 cells. Proc. Natl. Acad. Sci. USA. 86:1989;7410-7414.
160. Cmarik J.L., Herschman H., Colburn N.H. Preferential primary-response gene expression in promotion-resistant versus promotion-sensitive JB6 cells. Mol. Carcin. 11:1994;115-124.
161. Smith J.S. Jr, Wey H.E., Leikauf G.D., Baxter C.S. Carba-prostacyclin inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced transformation in sensitive murine epidermal JB6 cells. Carcinogenesis. 13:1992;1859-1862.
162. Gopalakrishna R., Gundimeda U., Anderson W.B., Colburn N.H., Slaga T.J. Tumor promoter benzoyl peroxide induces sulfhydryl oxidation in protein kinase C its reversibility is related to the cellular resistance to peroxide-induced cytotoxicity . Arch. Biochem. Biophys. 363:1999;246-258.
163. Hirano K., Smith B.M., Colburn N.H. Differential induction of 15 and 16 kDa nuclear proteins in promotion-sensitive and promotion-resistant mouse JB6 cells. Oncol. Res. 4:1992;17-21.
164. Kiss Z., Guyer B., Dong Z. Promotion-resistant JB6 mouse epidermal cells exhibit defects in phosphatidylethanolamine synthesis and phorbol ester-induced phosphatidylcholine hydrolysis. Biochem. J. 323:1997;489-495.
165. Banbura M., Ackland-Berglund C., Lee S.H., Hamernik D., Jones C. Analysis of transcriptional activation of a cyclic AMP response element by 2,6,10,14-tetramethylpentadecane (pristane) in JB6 mouse epidermal cells. Mol. Carcin. 11:1994;204-214.
166. Eto I. Promotion-sensitive epidermal and mammary epithelial cells maintained in suspension over agarose. Cell. Prolif. 31:1998;71-92.
167. Bernstein L.R., Walker S.E. Tumor promotion resistant cells are deficient in AP-1 DNA binding, JunD DNA binding and JunD expression and from different AP-1-DNA complexes than promotion sensitive cells. Biochim. Biophys. Acta. 1489:1999;263-280.
168. Cmarik J.L., Hegamyer G., Gerrard B., Dean M., Colburn N.H. cDNA cloning and mapping of mouse pleckstrin (Plek), a gene upregulated in transformation-resistant cells. Genomics. 66:2000;204-212.